EN
Current Location:Home ProductsPipeline

Pipeline

  • Drug
  • Target
  • Indication
  • Phase
  • BLA
  • Cooperation
PreclinicalPhase IPhase IIPhase III
赛乐信®
TargetIL-12/IL-23p40
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
Ps
Approved
CD
view more
QX005N
TargetIL-4Rα
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
AD
PN
CRSwNP
CSU
asthma
COPD
view more
QX002N
TargetIL-17A
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
AS
view more
QX004N
TargetIL-23p19
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
Ps
CD
view more
QX008N
TargetTSLP
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
asthma
COPD
view more
QX013N
Targetc-kit
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
CSU
view more
QX027N
TargetBsAb
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
asthma+AD
view more
QX030N
TargetBsAb
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
Undisclosed
view more
QX031N
TargetTSLP/IL-33
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
Respiratory
view more
QX035N
TargetBsAb
Indication
PhasePreclinicalPhase IPhase IIPhase IIIBLACollaboration
Respiratory+Skin
view more

AD: atopic dermatitis

CRSwNP: chronic rhinosinusitis with nasal polyps

Ps: psoriasis

AS: ankylosing spondylitis

CSU: chronic spontaneous urticaria

CD: Crohn’s disease

COPD: chronic obstructive pulmonary disease

PN: prurigo nodularis

IL-4Rα interleukin-4 receptor subunitα

IL-12/IL-23p40: interleukin-12/interleukin-23 subunit p40

IL-17A: interleukin-17A

IL-23p19: interleukin-23 subunit p19

TSLP: thymic stromal lymphopoietin
c-kit:type III receptor tyrosine kinase

BsAb: Bispecfic antibody


​​Pipeline updated to 2025-07